Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of NeuroVirology Année : 2020

Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient

Résumé

In HIV patients, HCV co-infection has been associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Furthermore, PML has also been described in patients with cirrhosis, whether related to HCV infection or not. We describe here the case of a HIV/HCV co-infected patient with cirrhosis who developed PML despite HIV suppression and CD4 cell count above 250/mm3 for 2 years. Immunological studies performed at onset of PML and before HCV therapy showed a decrease in naïve CD4 cells (CD45RA+CCR7+CD27+ CD4+ T cells - 23% cells, i.e. 75/mm3) and NK lymphopenia with abnormal and activated NK cells (CD3- CD16+ and/or CD56+) (5% lymphocytes, i.e. 58/mm3, CD69 91%, NKp30 26%). This impaired immunity, possibly related to HIV infection, or HCV infection or cirrhosis, or a combination thereof, could have led to the development of PML.
Fichier non déposé

Dates et versions

Identifiants

Citer

Maxime Hentzien, A. Guihot, Doé de Maindreville, T. Tabary, V. Brodard, et al.. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. Journal of NeuroVirology, 2020, 26 (4), pp.607-610. ⟨10.1007/s13365-020-00848-x⟩. ⟨hal-02883266⟩
51 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More